Cempra nets $54.7mm through IPO
Antibiotics developer Cempra Inc. has netted $54.7mm in its initial public offering of 9.66mm common shares (including the overallotment) at $6 each. Earlier this month the company announced plans to sell 6mm shares between $11-13.
- Large Molecule
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.